Benchmark Maintains Buy on Select Medical Hldgs, Raises Price Target to $48
Select Medical Hldgs Analyst Ratings
UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating
RBC Raises Price Target on Select Medical Holdings to $40 From $36, Keeps Outperform Rating
Select Medical Hldgs Analyst Ratings
Benchmark: Reiterates Select Medical Hldgs (SEM.US) rating and adjusted from buy to buy rating, target price is $39.00.
Select Medical Hldgs Analyst Ratings
Benchmark: Reiterates Select Medical Hldgs (SEM.US) rating and adjusted from buy to buy rating, target price is $39.00.
Select Medical Hldgs Analyst Ratings
Deutsche Bank Adjusts Price Target on Select Medical to $40 From $37, Maintains Buy Rating
UBS Initiates Coverage On Select Medical Hldgs With Neutral Rating, Announces Price Target of $26
Select Medical Hldgs Analyst Ratings
Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $39 Price Target
Select Medical Hldgs Analyst Ratings
RBC Cuts Price Target on Select Medical Holdings to $30 From $38, Keeps Outperform Rating
Credit Suisse Maintains Neutral on Select Medical Hldgs, Raises Price Target to $32
Select Medical Hldgs Analyst Ratings
RBC Capital Reiterates Outperform on Select Medical Hldgs, Maintains $38 Price Target
Select Medical Hldgs Analyst Ratings
RBC Lifts Price Target on Select Medical Holdings to $38 From $32, Cites Improved Labor Costs, Industry Multiple Expansion; Outperform Kept